Financials BioArctic AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 10:30:00 13/02/2026 pm IST			5-day change	1st Jan Change
322.20 ^SEK	+0.69%		+5.02%	+3.67%

09/02	Priority Review in China for Subcutaneous Leqembi Treatment	FW
06/02	Bioarctic reports Q4 sales of Leqembi at yen 20.7 billion	RE

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	65.94	23.15	229.9	616	257.4	1,994	1,133	1,843
Change	-	-64.9%	893.09%	167.99%	-58.22%	674.73%	-43.18%	62.69%
EBITDA ¹	-74	-126.6	-2.809	271.1	-	1,189	489.1	1,165
Change	-	-71.1%	97.78%	9,749.98%	-	-	-58.86%	138.19%
EBIT ¹	-85.01	-139.7	-17.44	252.6	-228.5	1,203	323.7	989.4
Change	-	-64.36%	87.52%	1,548.46%	-190.45%	626.35%	-73.09%	205.65%
Interest Paid ¹	-1.679	-0.79	-0.751	-10.38	-1.849	-3.1	-	-
Earnings before Tax (EBT) ¹	-86.69	-140.5	-11.17	276.5	-189.5	1,210	257.2	1,158
Change	-	-62.08%	92.05%	2,575.7%	-168.55%	738.19%	-78.74%	350.06%
Net income ¹	-68.52	-119.8	-11.18	229.2	-177.1	1,002	204.8	912.1
Change	-	-74.83%	90.67%	2,150.71%	-177.24%	665.62%	-79.55%	345.36%
Announcement Date	04/02/21	03/02/22	03/02/23	14/02/24	13/02/25	-	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2022 Q1	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	-	-	2.746	208.8	11.02	29.64	49.84	76.63	101.2	1,290	392.1	133.3	172.1	197.9	221.3	499.3	296
Change	-	-	-	7,505.17%	-94.72%	168.86%	68.17%	53.75%	32.1%	1,173.87%	-69.59%	-65.99%	29.06%	14.97%	11.83%	125.65%	-40.71%
EBITDA ¹	-	-	-	-	-	-	-	-	-	1,078	182.2	-25.4	-32	41	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-83.1%	-113.94%	-25.98%	228.12%	-	-	-
EBIT ¹	-	-	-100.9	131	-78.09	-73.1	-75.84	-26.08	-53.5	1,075	179.1	-28.77	-34.11	3.911	1.415	268.9	22
Change	-	-	-	229.88%	-159.6%	6.39%	-3.75%	65.62%	-105.15%	2,109.91%	-83.35%	-116.07%	-18.55%	111.47%	-63.82%	18,904.88%	-91.82%
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-	-	-	-	-	-	-	-	-	-	-	-20.94	-59	-27	-5	502	32
Change	-	-	-	-	-	-	-	-	-	-	-	-	-181.76%	54.24%	81.48%	10,140%	-93.63%
Net income ¹	-44.26	293.9	-	-	-	-	-68.42	-	-	1,021	-	-86.87	-47	-21	-4	396	25
Change	-	763.99%	-	-	-	-	-	-	-	-	-	-	45.9%	55.32%	80.95%	10,000%	-93.69%
Announcement Date	28/04/22	27/04/23	12/07/23	08/11/23	14/02/24	17/05/24	29/08/24	14/11/24	13/02/25	21/05/25	28/08/25	13/11/25	-	-	-	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	-979	-833	-795	-607	-459	-1,992	-1,680	-2,492
Change	-	14.91%	4.56%	23.65%	24.38%	-334.27%	15.66%	-48.33%
Announcement Date	04/02/21	03/02/22	03/02/23	14/02/24	13/02/25	-	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	-	-	12.76	7.443	26.64	16.33	17	16.67
Change	-	-	-	-41.68%	257.85%	-38.68%	4.08%	-1.96%
Free Cash Flow (FCF) ¹	-104.9	-144.8	-44.4	302.3	-343	2,025	-883.4	766.1
Change	-	-38.12%	69.35%	780.73%	-213.47%	690.44%	-143.62%	186.72%
Announcement Date	04/02/21	03/02/22	03/02/23	14/02/24	13/02/25	-	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-112.22%	-547.03%	-1.22%	44%	-	59.64%	43.17%	63.2%
EBIT Margin (%)	-128.92%	-603.66%	-7.59%	41.01%	-88.79%	60.33%	28.57%	53.68%
EBT Margin (%)	-131.46%	-607.07%	-4.86%	44.88%	-73.64%	60.66%	22.7%	62.8%
Net margin (%)	-103.9%	-517.54%	-4.86%	37.22%	-68.81%	50.24%	18.08%	49.48%
FCF margin (%)	-159.02%	-625.78%	-19.32%	49.07%	-133.27%	101.57%	-77.97%	41.56%
FCF / Net Income (%)	153.05%	120.92%	397.18%	131.84%	193.68%	202.18%	-431.35%	83.99%
Profitability
ROA	-6.13%	-12.3%	-1.27%	22.43%	-15.41%	75.5%	15.7%	51.4%
ROE	-7.28%	-14.13%	-7.1%	25.02%	-18.24%	71.95%	10%	35.03%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	5.55%	1.21%	10.35%	0.82%	1.5%	0.9%
CAPEX / EBITDA (%)	-	-	-454.36%	2.75%	-	1.37%	3.48%	1.43%
CAPEX / FCF (%)	-	-	-28.74%	2.46%	-7.77%	0.81%	-1.92%	2.18%
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	10.3	8.96	8.92	11.85	10.13	21.52	23.8	34.13
Change	-	-13.01%	-0.45%	32.85%	-14.51%	112.45%	10.59%	43.39%
EPS ¹	-0.78	-1.36	-0.13	2.59	-2	11.35	2.32	10.29
Change	-	-74.36%	90.44%	2,092.31%	-177.22%	667.5%	-79.56%	343.39%
Nbr of stocks (in thousands)	88,060	88,060	88,132	88,315	88,389	88,641	88,641	88,641
Announcement Date	04/02/21	03/02/22	03/02/23	14/02/24	13/02/25	-	-	-